The Caidya Story: Global Execution Where it Matters Most

Barbara Lopez Kunz, CEO of Caidya, discusses the company’s established presence in China and its ability to support biotechnology companies through full service and functional service provider models. She explains that Caidya’s capabilities in China were built to help sponsors navigate the Chinese regulatory system while also advancing their development programs internationally. The discussion highlights the scale of biotechnology innovation in China and the growing number of companies developing potentially valuable interventions. With operational capabilities originating in China and extending across global markets, Caidya is positioned to help Chinese biotechnology companies pursue approvals and take their clinical programs around the world.